Aspiriant Risk-Managed Equity Allc Adv (RMEAX)
| Fund Assets | 1.41B |
| Expense Ratio | 1.24% |
| Min. Investment | $0.00 |
| Turnover | 21.00% |
| Dividend (ttm) | 1.92 |
| Dividend Yield | 11.04% |
| Dividend Growth | 62.03% |
| Payout Frequency | Annual |
| Ex-Dividend Date | n/a |
| Previous Close | 17.45 |
| YTD Return | 7.25% |
| 1-Year Return | 16.54% |
| 5-Year Return | 40.69% |
| 52-Week Low | 15.36 |
| 52-Week High | 18.15 |
| Beta (5Y) | 0.66 |
| Holdings | 133 |
| Inception Date | Apr 4, 2013 |
About RMEAX
Aspiriant Risk-Managed Equity Allocation Fund Advisor Shares is a mutual fund designed to pursue long-term capital appreciation with a strong emphasis on risk management and tax efficiency. The fund invests predominantly in a diverse portfolio of equity securities—including common stocks, preferred stocks, and depositary receipts—spanning companies across both developed and emerging markets. It is structured to maintain at least 80% of its net assets in equity securities, with flexibility to use derivatives and alternative investment strategies for diversified exposure and risk control. Notable for its allocation to both high-quality and low-volatility equities, as well as long/short strategies through partnerships with sub-advisers and other investment vehicles, the fund aims to mitigate downside risk, particularly during periods of market turbulence. Tax-management strategies are incorporated throughout the investment process to enhance after-tax returns. The fund’s approach leverages quantitative models and forward-looking asset class forecasts to allocate assets dynamically in response to changing market conditions and valuations. By integrating these multiple strategies, Aspiriant Risk-Managed Equity Allocation Fund Advisor Shares provides investors with a globally diversified, risk-aware equity allocation solution that responds proactively to market risks and opportunities.
Performance
RMEAX had a total return of 16.54% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.06%.
Other Share Classes
These are alternative share classes of the same fund, from the same provider.
| Symbol | Share Class | Expense Ratio |
|---|---|---|
| RMEIX | Institutional Shares | 1.49% |
Top 10 Holdings
74.72% of assets| Name | Symbol | Weight |
|---|---|---|
| GMO Quality VI | GQLOX | 33.34% |
| Schwab Fundamental Emerging Markets Equity ETF | FNDE | 7.63% |
| Rief Strategic Partners Fund, Series SB | n/a | 7.15% |
| Baillie Gifford Emerging Markets Equities Fund | BGKEX | 5.01% |
| GMO Investments ICAV - GMO Equity Dislocation Investment Fund, Class A shares | IE00BF198X92 | 4.78% |
| AQR Large Cap Defensive Style R6 | QUERX | 4.04% |
| Viking Global Equities LP, Class H Interests | n/a | 3.91% |
| JPMorgan Prime Money Market Fund | JINXX | 3.43% |
| iShares MSCI Global Min Vol Factor ETF | ACWV | 3.11% |
| iShares MSCI ACWI ETF | ACWI | 2.32% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 23, 2025 | $1.9202 | Dec 23, 2025 |
| Dec 23, 2024 | $1.1851 | Dec 23, 2024 |
| Dec 21, 2023 | $0.7691 | Dec 21, 2023 |
| Dec 22, 2022 | $0.2835 | Dec 22, 2022 |
| Dec 30, 2021 | $0.383 | Dec 30, 2021 |
| Dec 30, 2020 | $0.2282 | Dec 30, 2020 |